drugset / Trial / NCT00596362

Treatment With Intravitreal Avastin for Large Uveal Melanomas

NCT00596362

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to test the safety and effectiveness of Avastin introduced into the inside of the eyeball in causing shrinkage of the uveal melanoma (tumor of the eye). Avastin is an anti-cancer drug specially designed to shrink blood vessels within tumors.

Timeline

Start
2007-04
Primary completion
2008-06
Completion
2008-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Bevacizumab Monoclonal antibody Intravitreal

Indications